Lipid-based mRNA vaccine delivery systems (Q38300777)

1 September 2017

1 reference

title

Lipid-based mRNA vaccine delivery systems (English)

1 reference

1 September 2017

1 reference

2

Chantal Pichon

1 reference

1 September 2017

Patrick Midoux

1

1 reference

1 September 2017

26 December 2014

1 reference

Expert Review of Vaccines

1 September 2017

1 reference

1 September 2017

14

1 reference

1 September 2017

221-234

1 reference

1 September 2017

2

1 reference

Challenges and advances towards the rational design of mRNA vaccines

1 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

mRNA-based therapeutics--developing a new class of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Vaccination with messenger RNA (mRNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Nonviral delivery of self-amplifying RNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

RNA replicon delivery via lipid-complexed PRINT protein particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Plasmid DNA- and messenger RNA-based anti-cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Emerging clinical applications of RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Nonviral vectors for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

The headgroup evolution of cationic lipids for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Structures of lipid-DNA complexes: supramolecular assembly and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Potentiation of cationic liposome-mediated gene delivery by polycations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Archaeosomes based on novel synthetic tetraether-type lipids for the development of oral delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Synthesis of archaeal bipolar lipid analogues: a way to versatile drug/gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Effects of a novel archaeal tetraether-based colipid on the in vivo gene transfer activity of two cationic amphiphiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Rational design of cationic lipids for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Size-dependent DNA mobility in cytoplasm and nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

DC-SIGN antagonists, a potential new class of anti-infectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

The effects of β-glucans on dendritic cells and implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

The Dectin-2 family of C-type lectin-like receptors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Development of new glycosylation methodologies for the synthesis of archaeal-derived glycolipid adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Glycomimetic building blocks: a divergent synthesis of epimers of shikimic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Quinoxalinone Inhibitors of the Lectin DC-SIGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Sonoporation: mechanistic insights and ongoing challenges for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

Second generation of fucose-based DC-SIGN ligands : affinity improvement and specificity versus Langerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.986104

10.1586/14760584.2015.986104

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25540984